Coming to APNS in 2028
Injuries involving ligaments, tendons, cartilage, muscles, and other connective tissues can be slow to heal. These tissues often have a limited blood supply, and recovery may require months of rehabilitation. Some injuries never fully return to their previous strength or function with rest alone.
APNS Injury & Repair will explore emerging adjunctive approaches intended to support the body’s natural healing processes. The future program will focus on theoretical and developing research involving peptides, selected corticosteroids, anabolic agents, nutritional support, and structured rehabilitation.
Why Injury and Repair Therapies Are Receiving Attention
Researchers are investigating whether certain medications and biological compounds can influence processes involved in tissue healing, including:
- Collagen production and organization
- Blood-vessel formation
- Inflammatory signaling
- Fibroblast and stem-cell activity
- Protein synthesis
- Muscle preservation
- Tendon-to-bone healing
- Cartilage metabolism
- Recovery after surgery or prolonged immobilization
Much of the interest comes from laboratory studies, animal research, sports medicine, orthopedic practice, and early human investigations. Preliminary findings have encouraged further study, but many promoted therapies have not yet been proven to regenerate damaged human tissue or improve long-term clinical outcomes.
Peptides and Tissue Repair
Peptides are short chains of amino acids that act as biological signaling molecules. Experimental peptides are being studied for possible effects on inflammation, blood-vessel growth, collagen formation, cell migration, and tissue remodeling.
Potential areas of investigation include:
- Tendon and ligament injuries
- Muscle strains and tears
- Cartilage damage
- Delayed recovery after surgery
- Overuse injuries
- Chronic soft-tissue conditions
- Recovery after prolonged inactivity
Some peptide claims are supported primarily by laboratory or animal studies. Many products marketed online as “healing peptides” are not FDA-approved, may not have been adequately tested in humans, and may have uncertain purity, potency, or sterility.
Corticosteroids and Anabolic Agents
Corticosteroids can reduce inflammation and provide symptom relief in selected musculoskeletal conditions. However, repeated or inappropriate corticosteroid exposure may weaken tendons, impair collagen production, affect cartilage, suppress immune function, or delay certain aspects of healing. Their role must therefore be carefully distinguished from therapies intended to promote tissue repair.
Anabolic agents increase protein-building activity and may help preserve or restore muscle in certain approved medical settings. Researchers have also explored whether anabolic signaling could support recovery after major injury, surgery, prolonged immobilization, or severe muscle loss.
However, anabolic drugs can carry substantial risks, including:
- Liver injury
- Abnormal cholesterol levels
- Increased blood pressure
- Blood thickening and clotting risk
- Heart and vascular complications
- Hormonal suppression
- Infertility
- Mood or behavioral changes
- Prostate-related effects
- Virilization in women
Many anabolic steroids are controlled substances. APNS does not prescribe, refill, or manage controlled substances. Any discussion of controlled anabolic agents within this program will be limited to education, medication reconciliation, contraindication screening, risk assessment, and coordination with appropriately licensed specialists.
A Combined Approach to Recovery
No medication can mechanically reconnect a completely ruptured tendon, stabilize a severely torn ligament, or reliably restore advanced cartilage loss. Some injuries require imaging, orthopedic evaluation, surgery, physical therapy, or other in-person treatment.
APNS Injury & Repair will be designed as an adjunctive program that may combine:
- Review of the injury and established diagnosis
- Coordination with orthopedic or sports-medicine care
- Physical therapy and progressive rehabilitation
- Evidence-informed nutrition and protein planning
- Correction of relevant nutritional deficiencies
- Sleep and recovery optimization
- Selected non-controlled prescription therapies
- Careful evaluation of emerging peptide treatments
- Monitoring of function, symptoms, and treatment safety
The goal will be to support healing, preserve strength, improve function, and help patients make informed decisions—not promise that an experimental treatment can regenerate every injured tissue.
Launching in 2028
The APNS Injury & Repair program is currently under development and is expected to launch in 2028. APNS is using this time to evaluate emerging human research, establish appropriate safety and monitoring standards, and determine which therapies can be responsibly offered through Telehealth.
Additional information about eligible injuries, available treatments, appointments, and pricing will be published as the program becomes available.